These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 37259170)

  • 1. Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications.
    Chen M; Jiang J; Hou J
    Biomark Res; 2023 May; 11(1):55. PubMed ID: 37259170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma.
    Bianchi G; Ghobrial IM
    Curr Cancer Ther Rev; 2014; 10(2):70-79. PubMed ID: 25705146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine.
    Dutta AK; Alberge JB; Sklavenitis-Pistofidis R; Lightbody ED; Getz G; Ghobrial IM
    Nat Rev Clin Oncol; 2022 Apr; 19(4):223-236. PubMed ID: 35017721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Cell Sequencing in Genitourinary Malignancies.
    Murphy N; Shah P; Shih A; Khalili H; Liew A; Zhu X; Lee A
    Adv Exp Med Biol; 2020; 1255():153-164. PubMed ID: 32949398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling the cellular landscape: insights from single-cell RNA sequencing in multiple myeloma.
    Li X; Lin Z; Zhao F; Huang T; Fan W; Cen L; Ma J
    Front Immunol; 2024; 15():1458638. PubMed ID: 39281682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of single-cell sequencing in cancer research: progress and perspectives.
    Lei Y; Tang R; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2021 Jun; 14(1):91. PubMed ID: 34108022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease.
    Dang M; Wang R; Lee HC; Patel KK; Becnel MR; Han G; Thomas SK; Hao D; Chu Y; Weber DM; Lin P; Lutter-Berka Z; Berrios Nolasco DA; Huang M; Bansal H; Song X; Zhang J; Futreal A; Moreno Rueda LY; Symer DE; Green MR; Rojas Hernandez CM; Kroll M; Afshar-Khargan V; Ndacayisaba LJ; Kuhn P; Neelapu SS; Orlowski RZ; Wang L; Manasanch EE
    Cancer Cell; 2023 Jun; 41(6):1032-1047.e4. PubMed ID: 37311413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Insights into the Initiation, Evolution, and Progression of Multiple Myeloma by Multi-Omics Investigation.
    Gong L; Qiu L; Hao M
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review.
    Nishihori T; Shain K
    Int J Genomics; 2017; 2017():6934183. PubMed ID: 29250532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Roles and Advantages of Single Cell Sequencing in the Diagnosis and Treatment of Hematological Malignancies.
    Shi M; Dong X; Huo L; Wei X; Wang F; Sun K
    Adv Exp Med Biol; 2018; 1068():119-133. PubMed ID: 29943300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value.
    Du J; Gu XR; Yu XX; Cao YJ; Hou J
    Blood Sci; 2023 Oct; 5(4):221-236. PubMed ID: 37941914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in single-cell sequencing technology in the field of hepatocellular carcinoma.
    Qin R; Zhao H; He Q; Li F; Li Y; Zhao H
    Front Genet; 2022; 13():996890. PubMed ID: 36303541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric antigen receptor T-cell therapy for multiple myeloma.
    Wang Z; Chen C; Wang L; Jia Y; Qin Y
    Front Immunol; 2022; 13():1050522. PubMed ID: 36618390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell profiling in multiple myeloma: insights, problems, and promises.
    Samur MK; Szalat R; Munshi NC
    Blood; 2023 Jul; 142(4):313-324. PubMed ID: 37196627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Cell RNA Sequencing in Hematological Diseases.
    Zhu Y; Huang Y; Tan Y; Zhao W; Tian Q
    Proteomics; 2020 Jul; 20(13):e1900228. PubMed ID: 32181578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathology and treatment of multiple myeloma understood from the tumor cell-of-origin perspective].
    Tanaka H
    Rinsho Ketsueki; 2020; 61(9):1317-1324. PubMed ID: 33162531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell sequencing in primary intraocular tumors: understanding heterogeneity, the microenvironment, and drug resistance.
    He LF; Mou P; Yang CH; Huang C; Shen Y; Zhang JD; Wei RL
    Front Immunol; 2023; 14():1194590. PubMed ID: 37359513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis beyond the cancer clone(s) in multiple myeloma.
    Bianchi G; Munshi NC
    Blood; 2015 May; 125(20):3049-58. PubMed ID: 25838343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Single-Cell Multi-Omics in Dissecting Cancer Cell Plasticity and Tumor Heterogeneity.
    Pan D; Jia D
    Front Mol Biosci; 2021; 8():757024. PubMed ID: 34722635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.